MISO Chip

AIM Biotech

This company develops organ-on-a-chip microfluidic platforms and research services for pharmaceutical firms and academic researchers to conduct preclinical human-tissue drug testing.

BiomimX

BiomimX develops organs-on-chip platforms that provide mechanical stimulation to 3D microtissues for drug and medical device testing by pharmaceutical and biotechnology companies.

Hooke Bio

This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.

Finnadvance

This company develops microfluidic organ-on-chip platforms for pharmaceutical and academic researchers to perform drug testing and mimic human organ functions.

MYLeukaemia

This company develops a bone-marrow-on-a-chip platform for functional precision oncology to test blood cancer drug efficacy for pharmaceutical companies and clinical researchers.

VitrofluidiX

VitrofluidiX develops an integrated organ-on-a-chip platform for pharmaceutical companies and research institutions to conduct predictive human biology testing without animal models.

MIMETAS

MIMETAS develops organ-on-a-chip tissue models and microfluidic culture plates for pharmaceutical companies to conduct drug discovery, toxicology screening and disease research.

ScreenIn3D Limited

This company develops microfluidic lab-on-a-chip platforms for drug developers to test therapies on patient-derived three-dimensional tumour samples.